New, improved method to find and isolate the strongest cancer-fighting immune cells

Article excerpt

A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could accelerate the creation of personalized treatments.